Sally Tucker - Chief Medical Officer & Senior Vice President of Clinical Development Good morning, and thank you for joining us today to delve into our gene therapy pipeline with a focus on our ...
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. TeLuRide-005, a Phase 2 trial of EIK1001 in ...
Bristol Myers Squibb and Hengrui Pharma have formed a broad global collaboration and license agreement that brings together 13 early‑stage programs across oncology, hematology, and immunology. The ...
WASHINGTON — Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a dual hub centered in the United States and China, according to ...
Bristol Myers Squibb (BMS) will partner with Hengrui Pharma to co-develop 13 early-stage programs in oncology, hematology, and immunology, the companies said today, through a collaboration that could ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results